Sponsor of the Day:
Jerkmate
https://www.statnews.com/2026/04/13/spyre-ibd-drug-success-early-trial/
Spyre Therapeutics inflammatory bowel disease drug shows promise in trial
Apr 13, 2026 - An inflammatory bowel disease treatment developed by Spyre Therapeutics sets the company up to compete with several large drugmakers.
inflammatory bowel diseasedrug shows promisespyretherapeuticstrial
https://www.biopharmadive.com/news/spyre-inflammatory-bowel-disease-drug-results-a4b7/817298/
Spyre drug for inflammatory bowel disease shows promise in early study | BioPharma Dive
The therapy, which works similarly to Takeda’s blockbuster Entyvio, showed remission rates that suggest a “best-in-class” profile, the company said.
inflammatory bowel diseaseshows promiseearly studybiopharma divespyre
https://www.biospace.com/employer/398104/spyre-therapeutics
Spyre Therapeutics - BioSpace
therapeutics biospacespyre